New International Assessment QuestionnaireGlobal Services and the Office of Compliance worked together to create the International Assessment Questionnaire (IAQ), which is hosted in REDCap.™
The IAQ has two main purposes:
- To assist the Office of Compliance in identifying activities that require additional assessment under export control and related regulations.
- To enable Global Services to provide assistance with the various administrative and business considerations (e.g., HR, travel) that international projects can involve.
Although export control regulations are quite complicated, the IAQ uses branching logic in an attempt to make it as straightforward as possible.
It is available at https://redcap.emory.edu/surveys/?s=CHEKWDRP4A. Only those researchers who answer “Yes” to either of the questions in the EPEX section entitled “International and Export Control Information” will need to follow the foregoing link to the IAQ. Completion of the IAQ is not a prerequisite to EPEX proposal submission. Accordingly, proposal submission will not be delayed by the IAQ. IAQ completion, however, is required prior to the distribution of funding.
Any questions about completing the IAQ should be directed to Chris Rapalje at firstname.lastname@example.org or David Giannantonio at email@example.com. Chris and David will be happy to field any questions and guide you through the process. They also will be working with administrators at the various schools to provide informational sessions for faculty and staff over the coming weeks.
Emory's new Office of Compliance
To help Emory navigate the complex regulatory landscape, the offices of research and administrative compliance have been integrated into the Office of Compliance. Kris West, J.D., M.S., has been named Emory’s first Chief Compliance Officer.
Follow us on Twitter:
Congratulations to the winners of the Compliance & Ethics Video Contest! Click here for more info and a link to the winning entry.
A new tutorial on the use of "Dangerous Drugs" in research is available.
NOTE: The FDA financial disclosure form is different from and is in addition to any financial disclosure forms that are required by NIH.